Smith & Nephew Skin-Prep Protective Dressing Qty 50

Product Information

Riccio LN, Swenson BR, Sawyer RG. The importance of isopropyl alcohol in skin preparation solutions. Infecti Control Hospi Epidemiol 2011; 32(4):405-6. Cruz D, Ocampo C, Brendolan A, et al. Effectiveness of sodium hypochlorite in the prevention of catheter related infections. Contrib Nephrol 2007; 154:97-102. Kunisada T, Yamada K, Oda S, Hara O. Investigation on the efficacy of povidone-iodine against antiseptic resistant species. Dermatology 1997; 195(Suppl 2):14-8.

Subject to the aforementioned limitations, the views expressed herein are those of CADTH and do not necessarily represent the views of Canada’s federal, provincial, or territorial governments or any third party supplier of information. In the cardiac literature, a comparison of DuraPrep solution with the leading PVP-I in patients at high risk for SSI undergoing open heart surgery, 4 of 101 patients in the DuraPrep solution group developed wound infections compared with 14 of 108 in the PVP-I group. 13 At another center, the introduction of DuraPrep solution in a cardiac surgery service was associated with a more than 50% reduction in overall SSI, sternal wound infection, and repeat surgical intervention for infection. 14CADTH is not responsible for any errors, omissions, injury, loss, or damage arising from or relating to the use (or misuse) of any information, statements, or conclusions contained in or implied by the contents of this document or any of the source materials. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999; 12(1):149-79. While care has been taken to ensure that the information prepared by CADTH in this document is accurate, complete, and up-to-date as at the applicable date the material was first published by CADTH, CADTH does not make any guarantees to that effect. CADTH does not guarantee and is not responsible for the quality, currency, propriety, accuracy, or reasonableness of any statements, information, or conclusions contained in any third-party materials used in preparing this document. The views and opinions of third parties published in this document do not necessarily state or reflect those of CADTH. There was no evidence on the use of skin antiseptics in babies. However, the committee were aware of risks, such as burns, associated with their use in this population, and wished to highlight this. The committee noted that the MHRA has published MHRA advice on the use of chlorhexidine for skin disinfection in premature babies.

Clean: an incision in which no inflammation is encountered in a surgical procedure, without a break in sterile technique, and during which the respiratory, alimentary or genitourinary tracts are not entered. MHRA would like to highlight that there are health risks associated with using chlorhexidine. Using the appropriately authorised product for its specific intended use, in accordance with the manufacturer’s instructions for use, is the best way of minimising harm. In babies less than 30 weeks gestational age a dabbing rather than rubbing technique should be employed to avoid skin irritation and excess absorption of the prepping solution. Skin preparation must be carried out as close as possible to commencement of the procedure with an antiseptic solution.

Chlorhexidine is also available in a non-medicinal form which is extensively and legitimately used for non-medicinal purposes, including in a clinical setting. These versions of the product are not subject to regulation under the Human Medicines Regulations 2012.